Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA

Lianne Kearsley-Fleet, Aasiyah Rokad, Man Fung Tsoi, Sizheng Zhao, Mark Lunt, Kath Watson, BSRBR-RA Contributors Group, Kimme Hyrich

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

2 results
- Title
- Date(ascending)

Etanercept biosimilar, originator produce similar outcomes in rheumatoid arthritis
Lianne Kearsley-Fleet
26/04/23
1 Media contribution
Press/Media: Other
Etanercept Biosimilar Comparable to Originator in Biologic-Naïve Patients With RA
Lianne Kearsley-Fleet
12/04/23
1 item of Media coverage
Press/Media: Other